30
Participants
Start Date
November 30, 2006
Primary Completion Date
June 30, 2009
Study Completion Date
July 31, 2015
sorafenib tosylate
Patients will receive treatment with 400mg of sorafenib, orally, twice daily, on a continuous basis as a single agent for at least 4 weeks, but not more than 8 weeks prior to their scheduled nephrectomy
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill